One Stop Shop for All Your Market Research Reports

Global Blood Plasma Derivatives Market Size, Status and Forecast 2021-2027

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used. The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market. Market Analysis and Insights: Global Blood Plasma Derivatives Market The global Blood Plasma Derivatives market size is projected to reach US$ 47030 million by 2027, from US$ 30890 million in 2020, at a CAGR of 5.7% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Plasma Derivatives market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Plasma Derivatives market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Plasma Derivatives market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Plasma Derivatives market. Global Blood Plasma Derivatives Scope and Market Size Blood Plasma Derivatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Plasma Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Albumin Factor VIII Factor IX Immunoglobulin Hyperimmune Globulin Others Segment by Application Hospitals Clinics Other End Users By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Grifols SK Plasma Fusion Health Care Biotest AG Green Cross Corporation Baxter International LFB Octapharma AG CSL Limited Takeda China Biologic Products Kedrion Biopharma BDI Pharma Bayer AG Hualan Biological Engineering
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Albumin 1.2.3 Factor VIII 1.2.4 Factor IX 1.2.5 Immunoglobulin 1.2.6 Hyperimmune Globulin 1.2.7 Others 1.3 Market by Application 1.3.1 Global Blood Plasma Derivativ
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Multi User US $5850
Corporate User US $7800
About this Report
Report ID 400163
  • Pharmaceuticals and Healthcare
Published on 23-Dec-21
Number of Pages 116
Publisher Name QY Research
Editor Rating